Descriptive Statistics for Radiation Dose Estimates (mGy/MBq) from HSA 123I-Iobenguane Distribution in 12 Healthy Adults
| Site | Mean | Minimum | Maximum | SD | COV |
| Urinary bladder wall | 7.3E−02 | 4.6E−02 | 8.6E−02 | 1.1E−02 | 15% |
| Lower large intestine wall | 7.1E−02 | 4.9E−02 | 9.6E−02 | 1.2E−02 | 17% |
| Salivary glands | 6.4E−02 | 3.5E−02 | 8.8E−02 | 1.4E−02 | 21% |
| Upper large intestine wall | 6.3E−02 | 4.3E−02 | 8.4E−02 | 1.0E−02 | 17% |
| Thyroid | 5.5E−02 | 3.9E−02 | 7.6E−02 | 9.4E−03 | 17% |
| Small intestine | 3.1E−02 | 2.3E−02 | 3.9E−02 | 4.0E−03 | 13% |
| Kidneys | 2.8E−02 | 2.3E−02 | 4.9E−02 | 7.0E−03 | 25% |
| Liver | 2.7E−02 | 2.2E−02 | 3.3E−02 | 3.8E−03 | 14% |
| Heart wall | 2.7E−02 | 1.9E−02 | 3.1E−02 | 3.3E−03 | 12% |
| Osteogenic cells | 2.4E−02 | 2.2E−02 | 2.7E−02 | 1.7E−03 | 7% |
| Ovaries | 2.2E−02 | 1.8E−02 | 2.6E−02 | 2.0E−03 | 9% |
| Uterus | 1.9E−02 | 1.7E−02 | 2.1E−02 | 9.7E−04 | 5% |
| Gallbladder wall | 1.7E−02 | 1.6E−02 | 1.9E−02 | 7.0E−04 | 4% |
| Spleen | 1.6E−02 | 1.3E−02 | 2.0E−02 | 1.9E−03 | 12% |
| Lungs | 1.5E−02 | 1.1E−02 | 1.8E−02 | 1.9E−03 | 12% |
| Pancreas | 1.2E−02 | 1.1E−02 | 1.3E−02 | 7.4E−04 | 6% |
| Adrenals | 1.2E−02 | 1.1E−02 | 1.3E−02 | 8.7E−04 | 7% |
| Stomach wall | 1.1E−02 | 1.0E−02 | 1.2E−02 | 5.6E−04 | 5% |
| Muscle | 8.8E−03 | 8.3E−03 | 9.5E−03 | 3.9E−04 | 4% |
| Red marrow | 8.7E−03 | 8.1E−03 | 9.3E−03 | 4.0E−04 | 5% |
| Thymus | 8.5E−03 | 7.4E−03 | 9.3E−03 | 6.3E−04 | 7% |
| Testes | 8.4E−03 | 7.9E−03 | 9.1E−03 | 3.4E−04 | 4% |
| Breasts | 6.1E−03 | 5.4E−03 | 6.6E−03 | 4.5E−04 | 7% |
| Skin | 5.3E−03 | 4.8E−03 | 5.9E−03 | 3.4E−04 | 6% |
| Brain | 4.0E−03 | 3.7E−03 | 4.6E−03 | 3.0E−04 | 8% |
| Total body | 1.0E−02 | 9.8E−03 | 1.1E−02 | 4.2E−04 | 4% |
| Effective dose (mSv/MBq) | 2.7E−02 | 2.3E−02 | 3.0E−02 | 1.9E−03 | 7% |
COV = coefficient of variation.